VR Logo

Ipca Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1949

Chairman: Premchand Godha

Managing Director: Premchand Godha

Group: Ipca Laboratories

Listing: NSE: IPCALAB, BSE: 524494

Headquarters: Mumbai, Maharashtra

Website: www.ipcalabs.com

Key Facts

Market cap: R 27,048.68 Cr

Revenue (TTM): R 5,104.92 Cr

Earnings (TTM): R 927.12 Cr

Cash: R 419.17 Cr

Total Debt: R 481.83 Cr

Promoters' ownership: 46.07%

Liquidity: High

52 Week range: R 844.65 - 2,236.10

Face value: R2.00

Shares outstanding: 12,68,52,109

10 Years Aggregate:

  • CFO: 4,344.31 Cr
  • EBITDA: 5,230.80 Cr
  • Net Profit: 3,198.24 Cr

Stock Performance

Time Period Ipca Laboratories S&P BSE Healthcare S&P BSE Mid Cap
YTD85.7746.78-1.81
1 month5.522.24-3.55
3 months25.4819.7312.42
1 Year127.0854.743.00
3 Years62.9013.47-1.62
5 Years23.032.436.71
10 Years20.8612.626.13
As on 29-Sep-2020
Year Ipca Laboratories S&P BSE Mid Cap S&P BSE Healthcare
201939.19-3.05-3.55
201833.85-13.31-5.89
201712.2448.130.49
2016-28.197.97-12.88
20152.957.4315.06
20141.3254.6947.43
201338.06-5.7322.55